FTHFX
Price
$58.18
Change
-$0.02 (-0.03%)
Updated
Jul 2 closing price
Net Assets
12.15B
PXSCX
Price
$22.25
Change
-$0.05 (-0.22%)
Updated
Jul 2 closing price
Net Assets
942.72M
Interact to see
Advertisement

FTHFX vs PXSCX

FTHFX vs PXSCX Comparison Chart in %
View a ticker or compare two or three
VS
FTHFX vs. PXSCX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTHFX is a Buy and PXSCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTHFX has more cash in the bank: 12.1B vs. PXSCX (943M). FTHFX pays higher dividends than PXSCX: FTHFX (0.57) vs PXSCX (0.00). FTHFX was incepted earlier than PXSCX: FTHFX (15 years) vs PXSCX (18 years). PXSCX (1.16) is less costly to investors than FTHFX (0.64). PXSCX is a more actively managed with annual turnover of: 36.00 vs. FTHFX (28.00). PXSCX has a lower initial minimum investment than FTHFX: PXSCX (1000) vs FTHFX (1000000). PXSCX annual gain was more profitable for investors over the last year : 30.19 vs. FTHFX (25.81). FTHFX return over 5 years is better than : 61.82 vs. PXSCX (14.15).
FTHFXPXSCXFTHFX / PXSCX
Total Expense Ratio0.641.1655%
Annual Report Gross Expense Ratio0.641.1655%
Fund Existence15 years18 years-
Gain YTD14.95822.05268%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.1B943M1,283%
Annual Yield % from dividends0.570.00-
Returns for 1 year25.8130.1985%
Returns for 3 years57.4245.71126%
Returns for 5 years61.8214.15437%
Returns for 10 years246.7362.74393%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LOGSX25.620.72
+2.89%
Live Oak Health Sciences
GTFPX35.500.47
+1.34%
Goldman Sachs International Eq ESG P
OMGNX63.380.16
+0.25%
Invesco Main Street R
QGRPX18.82-0.02
-0.11%
UBS US Quality Growth At Rsnbl Prc P
OSGCX11.72-0.13
-1.10%
JPMorgan Small Cap Growth C